‘Unlocking Success: Mastering your Real-World RMM Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 13 March 2025 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Antoine Pariente Director of the Department of Public Health & of the BPH AHeaD team – University of…
Read more
Free Live Online Masterclass RWE & Trials with Professor Stuart Pocock THE VALUE OF HIERARCHICAL COMPOSTE ENDPOINTS AND THE WIN RATIO: Experience in Clinical Trials and extension to Real World DATE: Wednesday, 22 January 2025, at 5pm CEST | 4pm UK time | 11am EST. Join Professor Stuart Pocock—one of the world’s leading experts in…
Read more
‘Unlocking Success: Mastering your RWE Pregnancy Studies Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Wednesday, 12 February 2025 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Helen Dolk Professor of Epidemiology and Health Services Research at Ulster University. REGISTER HERE Real-world evidence (RWE) plays…
Read more
OXON Epidemiology at the 21st Global CVCT Forum December 9-11, 2024 | Washington, DC OXON Epidemiology will be participating in the 21st Global CardioVascular Clinical Trialists Forum (CVCT), taking place in Washington, DC, from December 9 to December 11, 2024. This prestigious forum brings together global leaders in cardiovascular research, regulatory authorities, and industry experts…
Read more
OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services and new developments in RWE. OXON’s Epidemiology will be at the 9th Clinical Trial Summit in Barcelona to share how our Real-World Evidence (RWE)-driven clinical…
Read more
Evaluating ICDs’ Role in Reducing Sudden Cardiac Death Among High-Risk Patients OXON Epidemiology’s latest study, recently featured in JAMA Cardiology, provides critical insights into the effectiveness of implantable cardioverter-defibrillators (ICDs) compared to amiodarone in reducing sudden cardiac death among patients with chronic Chagas cardiomyopathy. Known as the CHAGASICS Randomized Clinical Trial, the study enrolled 323…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of Italy Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 24 October 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Carlo Giaquinto Professor of Paediatrics at the Department for Woman’s and Child’s Health of…
Read more
‘Unlocking Success: Mastering RWE Studies in the Healthcare Landscape of France Next session of the Free Live Online Webinar Series on RWE hosted by OXON Date: Thursday, 19 September 2024 Time: 5pm CEST | 11am EDT | 8am PST Speaker: Prof. Patrick Blin Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific…
Read more
OXON’s new RWE services and developments at ISPE Annual Meeting August 24-28, 2024 | Estrel Congress Center | Berlin, Germany OXON will be supporting ICPE 2024 as an exhibitor, showcasing expanded services and new developments in RWE. We are excited to announce that OXON’s Epidemiology team will be presenting and exhibiting at the ISPE 2024…
Read more
OXON Real-World Evidence Alzheimer’s Research in 2024 Lancet Report We are excited to announce that OXON’s Real-World Evidence (RWE) Alzheimer’s research has been prominently cited in the 2024 Lancet Commission on Dementia Report. This prestigious recognition underscores our commitment to advancing Alzheimer’s research and improving patient outcomes through evidence-based insights. Significant Contribution The Lancet Commission…
Read more
